1. From the Neurovascular Hypertension and Kidney Disease Laboratory/Human Neurotransmitters Laboratory (M.P.S., M.D.E.), Baker IDI Heart and Diabetes Institute and Alfred Hospital, Melbourne, Victoria, Australia; Department of Cardiology (P.A.S.), Hennepin County Medical Center, Minneapolis, Minn; Ardian, Inc (P.A.S.), Palo Alto, Calif; Monash Centre of Cardiovascular Research and Education in Therapeutics (H.K.), Department of Epidemiology and Preventive Medicine, Monash University, Melbourne,...